These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 10098741)
1. Dual mechanism of daunorubicin-induced cell death in both sensitive and MDR-resistant HL-60 cells. Côme MG; Skladanowski A; Larsen AK; Laurent G Br J Cancer; 1999 Mar; 79(7-8):1090-7. PubMed ID: 10098741 [TBL] [Abstract][Full Text] [Related]
2. Human stem cell factor-antibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells. Lu C; Hassan HT Leuk Res; 2006 Mar; 30(3):296-302. PubMed ID: 16112192 [TBL] [Abstract][Full Text] [Related]
3. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA. Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833 [TBL] [Abstract][Full Text] [Related]
4. P-glycoprotein expression does not change the apoptotic pathway induced by curcumin in HL-60 cells. Bielak-Mijewska A; Piwocka K; Magalska A; Sikora E Cancer Chemother Pharmacol; 2004 Feb; 53(2):179-85. PubMed ID: 14530869 [TBL] [Abstract][Full Text] [Related]
5. [Restorative effect of quercetin on subcellular distribution of daunorubicin in multidrug resistant leukemia cell lines K562/ADM and HL-60/ADM]. Cai X; Chen FY; Han JY; Gu CH; Zhong H; Ouyang RR Ai Zheng; 2004 Dec; 23(12):1611-5. PubMed ID: 15601547 [TBL] [Abstract][Full Text] [Related]
6. Relation among the resistance factor, kinetics of uptake, and kinetics of the P-glycoprotein-mediated efflux of doxorubicin, daunorubicin, 8-(S)-fluoroidarubicin, and idarubicin in multidrug-resistant K562 cells. Mankhetkorn S; Dubru F; Hesschenbrouck J; Fiallo M; Garnier-Suillerot A Mol Pharmacol; 1996 Mar; 49(3):532-9. PubMed ID: 8643093 [TBL] [Abstract][Full Text] [Related]
7. Combined Fourier transform infrared and Raman spectroscopic approach for identification of multidrug resistance phenotype in cancer cell lines. Krishna CM; Kegelaer G; Adt I; Rubin S; Kartha VB; Manfait M; Sockalingum GD Biopolymers; 2006 Aug; 82(5):462-70. PubMed ID: 16493658 [TBL] [Abstract][Full Text] [Related]
8. [Altered subcellular distribution of daunorubicin in the non-P-glycoprotein-mediated multidrug-resistant cell line HL-60/ADR]. Gong Y; Wang Y; Chen F; Han J; Shao N; Fang Z; Ouyang R Zhonghua Xue Ye Xue Za Zhi; 2000 Jun; 21(6):309-11, 2. PubMed ID: 11876999 [TBL] [Abstract][Full Text] [Related]
9. Subcellular distribution of daunorubicin in P-glycoprotein-positive and -negative drug-resistant cell lines using laser-assisted confocal microscopy. Gervasoni JE; Fields SZ; Krishna S; Baker MA; Rosado M; Thuraisamy K; Hindenburg AA; Taub RN Cancer Res; 1991 Sep; 51(18):4955-63. PubMed ID: 1680024 [TBL] [Abstract][Full Text] [Related]
10. Hypersensitization of multidrug resistant human ovarian carcinoma cells by pluronic P85 block copolymer. Alakhov VYu ; Moskaleva EYu ; Batrakova EV; Kabanov AV Bioconjug Chem; 1996; 7(2):209-16. PubMed ID: 8983343 [TBL] [Abstract][Full Text] [Related]
12. Cyclosporine diminishes multidrug resistance in K562/ADM cells and improves complete remission in patients with acute myeloid leukemia. Li GY; Liu JZ; Zhang B; Wang LX; Wang CB; Chen SG Biomed Pharmacother; 2009 Sep; 63(8):566-70. PubMed ID: 19095404 [TBL] [Abstract][Full Text] [Related]
13. Flow cytometric evaluation of fas expression in relation to response and resistance to anthracyclines in leukemic cells. Labroille G; Dumain P; Lacombe F; Belloc F Cytometry; 2000 Mar; 39(3):195-202. PubMed ID: 10685076 [TBL] [Abstract][Full Text] [Related]
14. Daunorubicin-induced internucleosomal DNA fragmentation in acute myeloid cell lines. Quillet-Mary A; Mansat V; Duchayne E; Come MG; Allouche M; Bailly JD; Bordier C; Laurent G Leukemia; 1996 Mar; 10(3):417-25. PubMed ID: 8642856 [TBL] [Abstract][Full Text] [Related]
15. Cell-specific modulation of drug resistance in acute myeloid leukemic blasts by diphtheria fusion toxin, DT388-GMCSF. Frankel AE; Hall PD; McLain C; Safa AR; Tagge EP; Kreitman RJ Bioconjug Chem; 1998; 9(4):490-6. PubMed ID: 9667951 [TBL] [Abstract][Full Text] [Related]
16. Susceptibility of idarubicin, daunorubicin, and their C-13 alcohol metabolites to transport-mediated multidrug resistance. Ross DD; Doyle LA; Yang W; Tong Y; Cornblatt B Biochem Pharmacol; 1995 Nov; 50(10):1673-83. PubMed ID: 7503771 [TBL] [Abstract][Full Text] [Related]
17. [Transfection of HL-60 cells with CYP3A5 gene induces drug-resistant phenotype]. Wang T; Chen FY; Gu CH; Zhong H; Teng Y; Ouyang RR Zhonghua Zhong Liu Za Zhi; 2005 Aug; 27(8):461-4. PubMed ID: 16188140 [TBL] [Abstract][Full Text] [Related]
18. A new apoptosis inhibitor, CIAPIN1 (cytokine-induced apoptosis inhibitor 1), mediates multidrug resistance in leukemia cells by regulating MDR-1, Bcl-2, and Bax. Li X; Hong L; Zhao Y; Jin H; Fan R; Du R; Xia L; Luo G; Fan D Biochem Cell Biol; 2007 Dec; 85(6):741-50. PubMed ID: 18059532 [TBL] [Abstract][Full Text] [Related]
19. Comparative evaluation of the intracellular accumulation and DNA binding of idarubicin and daunorubicin in sensitive and multidrug-resistant human leukaemia K562 cells. Bogush T; Robert J Anticancer Res; 1996; 16(1):365-8. PubMed ID: 8615637 [TBL] [Abstract][Full Text] [Related]
20. Persistent reversal of P-glycoprotein-mediated daunorubicin resistance by tetrandrine in multidrug-resistant human T lymphoblastoid leukemia MOLT-4 cells. Liu ZL; Hirano T; Tanaka S; Onda K; Oka K J Pharm Pharmacol; 2003 Nov; 55(11):1531-7. PubMed ID: 14713364 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]